Founder first
Exceptional companies begin with people who see the future differently. We listen closely to the founder before we evaluate the market.
Falcon Investment backs ambitious founders building the next generation of technology-led companies.
Our investment thesisWe invest in technology-led startups with the ambition to shape how people live, work, and build. We look beyond the obvious to find founders with clarity, technical depth, and the resolve to create enduring companies.
Our role is simple: recognize uncommon potential early, stand close through the difficult decisions, and stay committed for the journey ahead.
Exceptional companies begin with people who see the future differently. We listen closely to the founder before we evaluate the market.
We focus on businesses where science, engineering, software, or product innovation creates a durable advantage—not a temporary feature.
Building an important company takes time. We value candid relationships, patient thinking, and decisions that compound.
We are drawn to founders turning deep insight into technology that matters.
A sharp understanding of a problem others have overlooked or accepted.
Technology that creates meaningful and defensible product advantage.
The clarity, learning speed, and resilience to turn a bold idea into a company.
We are proud to partner with founders building technology-led companies for the future.
A B2B fintech platform that connects corporate treasury management with payments, authentication, and data through APIs.

Develops therapies for rare and autoimmune diseases, drawing on end-to-end expertise in antibody discovery and development.
Develops beauty ingredients and advanced regenerative therapies using human adipose-derived stem cells and extracellular matrix (ECM) technology.
Uses retinal imaging AI to predict cardiovascular and kidney disease risk without radiation and detect early signs of eye disease.

Produces high-performance films for automotive, semiconductor, and display applications through proprietary protective-film technology and ODM/OEM capabilities.
Connects clinical strategy design with remote patient monitoring, drawing on expertise in oncology clinical trials.
Building something
the world should know?